Soluble mast cell function associated antigen (MAFA) pharmaceutical compositions and methods of making and using them
This invention provides pharmaceutical compositions and methods for controlling and modifying Natural Killer (NK) cell and T cell functions by manipulation of "mast cell function-associated antigen," or "MAFA," polypeptide-mediated cell signaling. The invention provides a pharmac...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | eng |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Takahasi, Nobuaki Mikayama, Toshifumi |
description | This invention provides pharmaceutical compositions and methods for controlling and modifying Natural Killer (NK) cell and T cell functions by manipulation of "mast cell function-associated antigen," or "MAFA," polypeptide-mediated cell signaling. The invention provides a pharmaceutical compositions and methods using an agent that specifically binds to an MAFA ligand on a target cell and prevents or inhibits NK- or T cell-expressed cell surface MAFA from binding to the MAFA ligand on the target cell. Preventing or inhibiting an NK- or a T cell-expressed cell surface MAFA from binding to the MAFA ligand on the target cell prevents or inhibits the cell surface MAFA from generating an inhibitory signal to the NK or the T cell. The invention also provides pharmaceutical compositions and methods using an agent that specifically binds to an NK- or a T cell-expressed cell surface MAFA and prevents or inhibits the NK- or T cell-expressed cell surface MAFA from binding to a MAFA ligand or generating an inhibitory signal to the NK or the T cell. The invention also provides pharmaceutical compositions and methods using an agent that specifically binds to an NK- or a T cell-expressed cell surface MAFA and inhibits an NK cell or T cell activity. |
format | Patent |
fullrecord | <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07056677</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07056677</sourcerecordid><originalsourceid>FETCH-uspatents_grants_070566773</originalsourceid><addsrcrecordid>eNqNjbEKwkAQRK-xEPUfttRCCIhJHcRgY6W9rJdNcuTuNmT3_t-L-AFWMwxvZtYmPdintycIKAqWvIcuRauOI6AIW4dKLWBU11OE_b1u6gNMA84BLSV1Fj1YDhOLW0qS0RYC6cCtAHd5d3Sx_6ZJFqcDha1ZdeiFdj_dGGiuz8vtmGTKf1Hl1c-4SFEV57KsqtMfyAcpcEWX</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Soluble mast cell function associated antigen (MAFA) pharmaceutical compositions and methods of making and using them</title><source>USPTO Issued Patents</source><creator>Takahasi, Nobuaki ; Mikayama, Toshifumi</creator><creatorcontrib>Takahasi, Nobuaki ; Mikayama, Toshifumi ; Gemini Science, Inc</creatorcontrib><description>This invention provides pharmaceutical compositions and methods for controlling and modifying Natural Killer (NK) cell and T cell functions by manipulation of "mast cell function-associated antigen," or "MAFA," polypeptide-mediated cell signaling. The invention provides a pharmaceutical compositions and methods using an agent that specifically binds to an MAFA ligand on a target cell and prevents or inhibits NK- or T cell-expressed cell surface MAFA from binding to the MAFA ligand on the target cell. Preventing or inhibiting an NK- or a T cell-expressed cell surface MAFA from binding to the MAFA ligand on the target cell prevents or inhibits the cell surface MAFA from generating an inhibitory signal to the NK or the T cell. The invention also provides pharmaceutical compositions and methods using an agent that specifically binds to an NK- or a T cell-expressed cell surface MAFA and prevents or inhibits the NK- or T cell-expressed cell surface MAFA from binding to a MAFA ligand or generating an inhibitory signal to the NK or the T cell. The invention also provides pharmaceutical compositions and methods using an agent that specifically binds to an NK- or a T cell-expressed cell surface MAFA and inhibits an NK cell or T cell activity.</description><language>eng</language><creationdate>2006</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7056677$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64039</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7056677$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Takahasi, Nobuaki</creatorcontrib><creatorcontrib>Mikayama, Toshifumi</creatorcontrib><creatorcontrib>Gemini Science, Inc</creatorcontrib><title>Soluble mast cell function associated antigen (MAFA) pharmaceutical compositions and methods of making and using them</title><description>This invention provides pharmaceutical compositions and methods for controlling and modifying Natural Killer (NK) cell and T cell functions by manipulation of "mast cell function-associated antigen," or "MAFA," polypeptide-mediated cell signaling. The invention provides a pharmaceutical compositions and methods using an agent that specifically binds to an MAFA ligand on a target cell and prevents or inhibits NK- or T cell-expressed cell surface MAFA from binding to the MAFA ligand on the target cell. Preventing or inhibiting an NK- or a T cell-expressed cell surface MAFA from binding to the MAFA ligand on the target cell prevents or inhibits the cell surface MAFA from generating an inhibitory signal to the NK or the T cell. The invention also provides pharmaceutical compositions and methods using an agent that specifically binds to an NK- or a T cell-expressed cell surface MAFA and prevents or inhibits the NK- or T cell-expressed cell surface MAFA from binding to a MAFA ligand or generating an inhibitory signal to the NK or the T cell. The invention also provides pharmaceutical compositions and methods using an agent that specifically binds to an NK- or a T cell-expressed cell surface MAFA and inhibits an NK cell or T cell activity.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2006</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNqNjbEKwkAQRK-xEPUfttRCCIhJHcRgY6W9rJdNcuTuNmT3_t-L-AFWMwxvZtYmPdintycIKAqWvIcuRauOI6AIW4dKLWBU11OE_b1u6gNMA84BLSV1Fj1YDhOLW0qS0RYC6cCtAHd5d3Sx_6ZJFqcDha1ZdeiFdj_dGGiuz8vtmGTKf1Hl1c-4SFEV57KsqtMfyAcpcEWX</recordid><startdate>20060606</startdate><enddate>20060606</enddate><creator>Takahasi, Nobuaki</creator><creator>Mikayama, Toshifumi</creator><scope>EFH</scope></search><sort><creationdate>20060606</creationdate><title>Soluble mast cell function associated antigen (MAFA) pharmaceutical compositions and methods of making and using them</title><author>Takahasi, Nobuaki ; Mikayama, Toshifumi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_070566773</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2006</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Takahasi, Nobuaki</creatorcontrib><creatorcontrib>Mikayama, Toshifumi</creatorcontrib><creatorcontrib>Gemini Science, Inc</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Takahasi, Nobuaki</au><au>Mikayama, Toshifumi</au><aucorp>Gemini Science, Inc</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Soluble mast cell function associated antigen (MAFA) pharmaceutical compositions and methods of making and using them</title><date>2006-06-06</date><risdate>2006</risdate><abstract>This invention provides pharmaceutical compositions and methods for controlling and modifying Natural Killer (NK) cell and T cell functions by manipulation of "mast cell function-associated antigen," or "MAFA," polypeptide-mediated cell signaling. The invention provides a pharmaceutical compositions and methods using an agent that specifically binds to an MAFA ligand on a target cell and prevents or inhibits NK- or T cell-expressed cell surface MAFA from binding to the MAFA ligand on the target cell. Preventing or inhibiting an NK- or a T cell-expressed cell surface MAFA from binding to the MAFA ligand on the target cell prevents or inhibits the cell surface MAFA from generating an inhibitory signal to the NK or the T cell. The invention also provides pharmaceutical compositions and methods using an agent that specifically binds to an NK- or a T cell-expressed cell surface MAFA and prevents or inhibits the NK- or T cell-expressed cell surface MAFA from binding to a MAFA ligand or generating an inhibitory signal to the NK or the T cell. The invention also provides pharmaceutical compositions and methods using an agent that specifically binds to an NK- or a T cell-expressed cell surface MAFA and inhibits an NK cell or T cell activity.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_uspatents_grants_07056677 |
source | USPTO Issued Patents |
title | Soluble mast cell function associated antigen (MAFA) pharmaceutical compositions and methods of making and using them |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T23%3A56%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Takahasi,%20Nobuaki&rft.aucorp=Gemini%20Science,%20Inc&rft.date=2006-06-06&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07056677%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |